Australian scientists have successfully used an innovative gene therapy technique in the lab to combat a key cause of vision ...
Patients with wet age-related macular degeneration receiving CLS-AX achieved stable visual acuity, and retinal thickness for ...
“These are devastating diseases with limited treatment options,” said Curt Breneman, Ph.D., dean of Rensselaer’s School of ...
News Medical on MSN4d
Scientists discover novel compound to combat age-related blindnessRensselaer Polytechnic Institute's Christopher Cioffi, Ph.D., Thomas and Constance D'Ambra Professor in Organic Chemistry, has been collaborating with Konstantin Petrukhin, Ph.D., Professor of ...
Researchers receive $6.4 million grant from NEI to seek new treatment for blindness-causing diseases
Rensselaer researchers receive $6.4 million grant from NEI to seek new treatment for blindness-causing diseases.
EyePoint Pharmaceuticals' shares rise as interim Phase 2 VERONA trial data shows Duravyu improves visual acuity and anatomy ...
Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...
Biosimilar aflibercept (P041) demonstrated comparable safety and efficacy to the originator aflibercept (Eylea) in treating patients with retinal conditions like neovascular age-related macular ...
Dr. Shiri Shulman from Assuta discusses the importance of continuity in treatment during wartime and innovative therapies ...
As people live longer than ever before, the incidence of aging-related, chronic diseases is on the rise, severely impacting ...
2008;3(3):311-323. Choroidal neovascularization in PM has been treated with different approaches, which include laser photocoagulation, submacular surgery, photodynamic therapy (PDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback